HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuan-Chin Tsai Selected Research

2- methyl- 2- ((1- (3- phenyl- 7- propylbenzo(d)isoxazol- 6- yl)oxy)propyl)- 1H- 4- indolyloxypropanoic acid

2/2008A novel peroxisome proliferator-activated receptor alpha/gamma agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuan-Chin Tsai Research Topics

Disease

15Neoplasms (Cancer)
12/2020 - 12/2006
8Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2017
2Inflammation (Inflammations)
12/2020 - 03/2020
2Adenocarcinoma
12/2020 - 03/2020
2Anaplastic Thyroid Carcinoma
01/2018 - 12/2017
2Neoplasm Metastasis (Metastasis)
08/2017 - 01/2017
2Infections
06/2015 - 08/2004
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1Carcinoma (Carcinomatosis)
12/2020
1Virus Diseases (Viral Diseases)
06/2015
1Leukemia
08/2010
1Mouth Neoplasms (Oral Cancer)
02/2008
1Diabetes Mellitus
02/2008
1Ataxia Telangiectasia (Louis Bar Syndrome)
02/2008
1Cardiotoxicity
09/2007
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2007
1Melanoma (Melanoma, Malignant)
06/2007
1Carcinogenesis
06/2007
1Breast Neoplasms (Breast Cancer)
12/2006

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2015
3AndrogensIBA
12/2020 - 08/2017
3DNA (Deoxyribonucleic Acid)IBA
06/2015 - 09/2007
3Type II DNA Topoisomerases (Topoisomerase II)IBA
08/2010 - 06/2007
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
12/2020 - 03/2020
2Androgen Receptors (Androgen Receptor)IBA
05/2018 - 08/2017
2ErbB Receptors (EGF Receptor)IBA
01/2018 - 01/2017
2IsoenzymesIBA
08/2010 - 06/2007
1Tumor Biomarkers (Tumor Markers)IBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1InterleukinsIBA
12/2020
1ChemokinesIBA
03/2020
1LigandsIBA
05/2018
1CC ChemokinesIBA
05/2018
1Proto-Oncogene Proteins c-etsIBA
05/2018
1Coenzyme A (CoA)IBA
01/2018
1Lovastatin (Mevacor)FDA LinkGeneric
01/2018
1PPAR gammaIBA
01/2018
1Pharmaceutical PreparationsIBA
01/2018
1Tyrosine Kinase InhibitorsIBA
01/2018
1Oxidoreductases (Dehydrogenase)IBA
01/2018
1Troglitazone (Rezulin)FDA Link
01/2018
1Simvastatin (Zocor)FDA LinkGeneric
12/2017
1Carrier Proteins (Binding Protein)IBA
08/2017
1CollagenIBA
08/2017
1Transcription Factors (Transcription Factor)IBA
08/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
08/2017
1Biological ProductsIBA
01/2017
1Viral ProteinsIBA
06/2015
1EnzymesIBA
06/2015
1MethyltransferasesIBA
06/2015
1Ribosomal DNA (rDNA)IBA
01/2014
1IsothiocyanatesIBA
09/2011
1CarcinogensIBA
09/2011
1Proteasome Endopeptidase Complex (Proteasome)IBA
08/2010
1GenisteinIBA
08/2010
1Telomerase (Telomerase Reverse Transcriptase)IBA
08/2009
1methylamine (methylammonium)IBA
08/2008
12-propylamine (isopropylamine)IBA
08/2008
1Antineoplastic Agents (Antineoplastics)IBA
08/2008
1PPAR alphaIBA
02/2008
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2008
1Etoposide (VP 16)FDA LinkGeneric
02/2008
12- methyl- 2- ((1- (3- phenyl- 7- propylbenzo(d)isoxazol- 6- yl)oxy)propyl)- 1H- 4- indolyloxypropanoic acidIBA
02/2008
1PPAR-gamma AgonistsIBA
02/2008
1trioctyl phosphine oxide (TOPO)IBA
02/2008
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2007
1Dexrazoxane (Zinecard)FDA LinkGeneric
09/2007
1anthraceneIBA
06/2007
1OligodeoxyribonucleotidesIBA
12/2006
1Antiviral Agents (Antivirals)IBA
08/2004
1Interferon-alpha (Interferon Alfa)IBA
08/2004
1Arsenic Trioxide (Trisenox)FDA Link
08/2004

Therapy/Procedure

5Castration
12/2020 - 08/2017
5Therapeutics
05/2018 - 08/2004
1Drug Therapy (Chemotherapy)
06/2007